Fundz

Mainz Biomed N.V. Acquires Quantum Cyber to Enhance Cybersecurity Strategy

PUBLIC · QUCYMar 17, 2026

Acquiring Company

Quantum Cyber N.V.

Acquired Company

Quantum Cyber N.V.

BerkeleyBerkeleyInformation TechnologyBiotechnologyHealth CareMedicalCyber SecurityNetwork SecurityHealth DiagnosticsInformation TechnologyBiotechnologyHealth CareMedicalCyber SecurityNetwork SecurityHealth Diagnostics

Description

On March 17, 2026, Mainz Biomed N.V. announced its acquisition of Quantum Cyber as part of its strategy to align with national cyber security frameworks. This acquisition is aimed at expanding Mainz Biomed's capabilities in the quantum and cyber defense sectors. The company seeks to enhance its offerings by integrating advanced security solutions.

Quick answer

Quantum Cyber N.V. is acquiring Quantum Cyber N.V., announced March 17, 2026. Quantum Cyber N.V. is based in Berkeley, California, United States.

Who acquired Quantum Cyber N.V?
Quantum Cyber N.V. agreed to acquire Quantum Cyber N.V. on March 17, 2026.
How much did Quantum Cyber N.V. pay for Quantum Cyber N.V?
The deal value was not disclosed.
Where are Quantum Cyber N.V. and Quantum Cyber N.V. based?
Quantum Cyber N.V. is based in Berkeley, California, United States. Quantum Cyber N.V. is based in Berkeley, California, United States.
Who are the decision-makers at Quantum Cyber N.V?
Fundz holds 1 contact at Quantum Cyber N.V. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Cyber Security

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Quantum Cyber N.V., and when

When Quantum Cyber N.V. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Quantum Cyber N.V. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Quantum Cyber N.V., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Quantum Cyber N.V.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Quantum Cyber N.V.

Location

ROBERT KOCH STRASSE 50

Berkeley, California, United States

About

Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert®, an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. ColoAlert® is currently marketed across Europe. The Company is running a pivotal FDA clinical study for US regulatory approval. Mainz Biomed’s product candidate portfolio also includes PancAlert, an early-stage pancreatic cancer screening test. To learn more, visit mainzbiomed.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Quantum Cyber N.V. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Marco
Senior decision-maker at this company
••••••••@••••••••

See Marco's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Quantum Cyber N.V.'s next move

Learn about Strategic plan

Frequently asked

Who acquired Quantum Cyber N.V.?

Quantum Cyber N.V. was acquired by Quantum Cyber N.V., based in Berkeley. The deal was reported on March 17, 2026. Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. Quantum Cyber N.V. is publicly traded (QUCY) and operates in Information Technology.

When did Quantum Cyber N.V. acquire Quantum Cyber N.V.?

Quantum Cyber N.V.'s acquisition of Quantum Cyber N.V. was reported on March 17, 2026. On March 17, 2026, Mainz Biomed N.V. announced its acquisition of Quantum Cyber as part of its strategy to align with national cyber security frameworks. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Quantum Cyber N.V. do?

Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is publicly traded (QUCY), operating in Information Technology, and is based in Berkeley.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.